Compounds > fibrinogen
Page last updated: 2024-08-26

fibrinogen and Cardiac Failure

fibrinogen has been researched along with Cardiac Failure in 82 studies

Research

Studies (82)

TimeframeStudies, this research(%)All Research%
pre-199025 (30.49)18.7374
1990's9 (10.98)18.2507
2000's18 (21.95)29.6817
2010's20 (24.39)24.3611
2020's10 (12.20)2.80

Authors

AuthorsStudies
Al-Kindi, SG; Badhwar, AK; Carneiro, H; Chami, T; Hajjari, J; Janus, SE; Karnib, M; Mously, H; Rahman, M1
Araujo-Gutierrez, R; Bhimaraj, A; Cruz-Solbes, AS; El Nihum, LI; Estep, J; Graviss, EA; Guha, A; Hannawi, B; Hussain, I; Kassi, M; Kenneth Sims, R; Kim, JH; Nguyen, DT; Srour, N; Trachtenberg, BH1
Chang, L; Chen, J; Dai, Q; Gu, R; Hu, L; Huang, R; Wang, L; Wang, Z; Xu, B; Zheng, H1
Hu, Z; Ji, K; Qian, L; Xu, Q; Zhang, Q; Zhu, C1
He, D; Li, Z; Song, J; Sun, Z; Yu, T1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J1
Angleitner, P; Laufer, G; Michalovics, P; Moscato, F; Riebandt, J; Schima, H; Schlöglhofer, T; Stoiber, M; Wiedemann, D; Zimpfer, D1
He, Y; Meng, Z; Zhao, Y1
Fan, C; Huang, S; Liu, H; Liu, K; Wang, Z; You, Y1
Andrijevic, I; Andrijevic, L; Jokic, D; Milutinov, S; Vukoja, M1
Clark, SL; Hankins, GDV; Klassen, M; Pacheco, LD1
Kawada, T1
Barac, A; de Simone, G; Devereux, RB; Howard, BV; Panza, JA; Shara, NM; Wang, H1
Aksoy, F; Dogan, A; Erdogan, D; Karabacak, M; Karabacak, P; Ozaydin, M1
Catena, C; Colussi, G; Fedrizzi, S; Sechi, LA1
Alam, A; Cserti-Gazdewich, C; Pendergrast, J1
Behar, S; Benderly, M; Eisen, A; Goldbourt, U; Haim, M1
Bhutta, AT; Byrnes, JW; Dyamenahalli, U; Garcia, X; Gomez, A; Imamura, M; Jaquiss, RD; Johnson, C; Prodhan, P; Rettiganti, MR1
Baraki, H; Haverich, A; Kutschka, I; Martens, A; Martin, U; Rathert, C; Rojas, SV; Rojas-Hernandez, S; Schecker, N; Schwanke, K; Zweigerdt, R1
Garbacz, M; Kaczmarski, J; Kuliczkowski, W; Pacholewicz, J; Serebruany, V; Zakliczyński, M; Zembala, M1
Petrova, OV; Shashin, SA; Tarasov, DG1
Kunutsor, SK; Kurl, S; Laukkanen, JA; Zaccardi, F1
Kubilius, R; Mongirdienė, A1
Antoniades, C; Drolias, A; Gounari, P; Latsios, G; Marinou, K; Papageorgiou, N; Siasos, G; Stefanadi, E; Stefanadis, C; Tousoulis, D; Trikas, A; Vasiliadou, C1
Cichowski, L; Sadowski, J; Salczyńska, D; Targoński, R1
Acconcia, C; Angelino, A; Balsano, F; Di Girolamo, F; Diurni, V; Fravolini, F; Mancusi, C; Molfetta, R; Morelli, S1
Sanfelippo, MJ; Scherr, DL; Shaw, GR; Zinsmaster, W1
Cushman, M; Furberg, C; Jenny, NS; Nelson, JJ; Psaty, BM; Solomon, C; Suzuki, T; Tracy, R1
Bahrami, H; Bluemke, DA; Cushman, M; Fernandes, V; Lima, JA; Nasir, K; Redheuil, A; Tracy, R; Vogel-Claussen, J; Yan, AT; Yan, RT1
Brunini, TM; Cascarelli, PG; de Meirelles, LR; Matsuura, C; Mendes-Ribeiro, AC; Pereira, NR; Resende, Ade C; Salgado, A1
Barac, A; Best, LG; Carter, EA; de Simone, G; Devereux, RB; Dixon, DB; Howard, BV; Panza, JA; Shara, NM; Umans, JG; Wang, H; Yeh, J1
Amerikanou, R; Besser, MW; Large, S; Lawrence, K; MacDonald, S1
Aispuru, GR; Barousse, AP; Cardone, AJ; Clavier, MM; Gilberto, DO1
Dahl, M; Lange, P; Nordestgaard, BG; Thomsen, M; Vestbo, J1
Augusto, M; Caldin, M; Drigo, M; Zoia, A1
Blann, AD; Chin, BS; Chung, NA; Gibbs, CR; Lip, GY1
Bellini, MA; Boschi, L; Forconi, S; Guerrini, M; Pallassini, A; Postorino, G; Richichi, MG; Trabalzini, L; Turchetti, V1
Bauersachs, J; Christ, M; Eigenthaler, M; Fraccarollo, D; Hildemann, S; Kobsar, A; Schäfer, A; Walter, U1
Blann, AD; Chin, BS; Gibbs, CR; Lip, GY1
EISENBERG, S1
Blann, AD; Chin, BS; Chung, NA; Conway, DG; Gibbs, CR; Lip, GY1
Borghi, MO; Bottasso, B; Coppola, R; Cugno, M; Frigerio, M; Gregorini, L; Gronda, E; Mari, D; Meroni, PL; Vicari, F1
Parish, JM; Somers, VK1
Aksakal, E; Demircan, S; Sağkan, O; Sahin, M; Yazici, M1
Bella, JN; Best, LG; Devereux, RB; Kizer, JR; Lee, ET; Liu, JE; Palmieri, V; Roman, MJ1
Clark, AL; Ford, SJ; Parker, JD; Preston, T; Witte, KK1
Agostoni, P; Banfi, C; Barcella, S; Biglioli, P; Brioschi, M; Tremoli, E; Veglia, F1
Johansson, SA1
Greenberg, J; Yudelman, I1
Panchenko, EP1
Bolińska, H; Judkiewicz, L; Khawam, E; Niewiarowska, J; Wasiak-Radzikowska, M1
Mayer, J; Novotný, J; Spinar, J; Spinarová, L; Vítovec, J1
Linke, J1
Goto, S; Hande, S; Ikeda, Y; Sakai, H1
Hetzel, J; Hoffmeister, A; Hombach, V; Koenig, W; Kron, M; Sander, S1
Kang, J; Matsumura, T; Miyai, I; Nozaki, S; Saito, T; Takenaka, M; Yamamoto, Y1
Blann, AD; Edmunds, E; Gibbs, CR; Lip, GY; Watson, RD1
Alkjaersig, NK; Fletcher, AP; Ghani, FM; Owens, O; Tulevski, V1
Belousov, IuB; Liusov, VA; Panchenko, EP; Savenkov, MP; Sidorskiĭ, AL1
Abazova, FI; Belousov, IuB; Savenkov, MP; Sidorskiĭ, AL1
Mayer, G; Schomerus, H1
Amsterdam, EA; Carretta, RF; DeNardo, GL; Kraus, JF; Lies, JE; Mason, DT; Miller, RR; Wampold, DB1
Bulin, VA; Iliushina, IP; Mazur, NA; Metalitsa, VI; Zhukov, VN1
Glauser, FL; Levine, RI; Otis, PT; Smith, WR1
Duncan, A; Henderson, JM; Hooks, MA; Martin, LG; Stahl, RL1
Bowie, EJ; Daniels, TM; Gastineau, DA; Gertz, MA; Kyle, RA1
Gottlieb, SS; Haber, HL; Kessler, PD; Kukin, ML; Leavy, JA; Packer, M1
Alexander, HM; Dobson, AJ; Heller, RF; Lloyd, DM1
McNicol, GP; Prentice, CR; Wood, EH1
Douglas, AS; Ogston, D; Rawles, JM1
Lagrue, G; Vernant, JP1
Ottolander, GJ; Schopmen, W; van der Maas, AP1
den Ottolander, GJ; Schopman, W; Teulings, FA; van der Maas, AP1
Baele, G; Barbier, F; Mussche, M; Pannier, R; Vermeire, P1
Larmi, TK1
Anderson, ST; Habersberger, PG; Pitt, A1
Ikkala, E; Kotilainen, M; Pyörälä, K; Ristola, P1
Pinkus, SSh1
Abildgaard, CF; Forman, EN; Gotoff, SP; Honig, GR; Lindley, A; Schulman, I1
Cucuianu, M; Hărăguş, S; Missits, P1

Reviews

3 review(s) available for fibrinogen and Cardiac Failure

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Baseline and long-term fibrinogen levels and risk of sudden cardiac death: A new prospective study and meta-analysis.
    Atherosclerosis, 2016, Volume: 245

    Topics: Biomarkers; Death, Sudden, Cardiac; Fibrinogen; Global Health; Heart Failure; Humans; Prospective Studies; Risk Assessment; Risk Factors

2016
Obstructive sleep apnea and cardiovascular disease.
    Mayo Clinic proceedings, 2004, Volume: 79, Issue:8

    Topics: Arousal; Arrhythmias, Cardiac; Arteriosclerosis; C-Reactive Protein; Cardiovascular Diseases; Coronary Disease; Fatigue; Fibrinogen; Heart Failure; Humans; Hypertension; Hypertension, Pulmonary; Interleukin-6; Ischemic Attack, Transient; Oxyhemoglobins; Plasminogen Inactivators; Platelet Aggregation; Polysomnography; Prevalence; Risk Factors; Severity of Illness Index; Sleep Apnea, Obstructive; Stroke

2004

Trials

7 trial(s) available for fibrinogen and Cardiac Failure

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Both carvedilol and nebivolol may improve platelet function and prothrombotic state in patients with nonischemic heart failure.
    Angiology, 2014, Volume: 65, Issue:6

    Topics: Adrenergic beta-1 Receptor Antagonists; Benzopyrans; Carbazoles; Carvedilol; Drug Therapy, Combination; Ethanolamines; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Failure; Humans; Male; Mean Platelet Volume; Middle Aged; Nebivolol; Propanolamines; Single-Blind Method

2014
Inflammation and future risk of symptomatic heart failure in patients with stable coronary artery disease.
    American heart journal, 2014, Volume: 167, Issue:5

    Topics: Age Factors; Aged; Bezafibrate; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Female; Fibrinogen; Follow-Up Studies; Heart Failure; Humans; Hypolipidemic Agents; Incidence; Inflammation; Israel; Leukocyte Count; Male; Middle Aged; Risk Factors; Time Factors

2014
Antidepressive treatment as a modulator of inflammatory process in patients with heart failure: effects on proinflammatory cytokines and acute phase protein levels.
    International journal of cardiology, 2009, May-15, Volume: 134, Issue:2

    Topics: Acute-Phase Proteins; Antidepressive Agents, Tricyclic; C-Reactive Protein; Cross-Sectional Studies; Depressive Disorder, Major; Female; Fibrinogen; Heart Failure; Humans; Immune System; Interleukin-6; Male; Middle Aged; Multivariate Analysis; Norepinephrine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Tumor Necrosis Factor-alpha

2009
Prevention of lower extremity venous thrombosis by early mobilization. Confirmation in patients with acute myocardial infarction by 125I-fibrinogen uptake and venography.
    Annals of internal medicine, 1976, Volume: 84, Issue:6

    Topics: Acute Disease; Adult; Aged; Early Ambulation; Female; Fibrinogen; Heart Failure; Humans; Iodine Radioisotopes; Leg; Male; Middle Aged; Myocardial Infarction; Phlebography; Thrombophlebitis; Time Factors

1976
[Fibrinolytic activity and blood fibrinogen in patients with rheumatic heart disease].
    Terapevticheskii arkhiv, 1967, Volume: 39, Issue:9

    Topics: Clinical Trials as Topic; Fibrinogen; Fibrinolysis; Heart Failure; Humans; Rheumatic Heart Disease

1967
Urokinase pulmonary embolism trial. Phase 1 results: a cooperative study.
    JAMA, 1970, Dec-21, Volume: 214, Issue:12

    Topics: Angiography; Female; Fibrinogen; Fibrinolytic Agents; Heart Failure; Hematocrit; Hemorrhage; Heparin; Humans; Male; Middle Aged; Plasminogen; Pulmonary Artery; Pulmonary Embolism; Radionuclide Imaging; Serum Globulins; Time Factors

1970

Other Studies

73 other study(ies) available for fibrinogen and Cardiac Failure

ArticleYear
Multi-variable biomarker approach in identifying incident heart failure in chronic kidney disease: results from the Chronic Renal Insufficiency Cohort study.
    European journal of heart failure, 2022, Volume: 24, Issue:6

    Topics: Adult; Biomarkers; Cohort Studies; Fibrinogen; Fibroblast Growth Factors; Heart Failure; Humans; Natriuretic Peptide, Brain; Renal Insufficiency, Chronic; Risk Factors

2022
Tissue plasminogen activator in left ventricular assist device-related intravascular hemolysis after failed augmented anticoagulation.
    The International journal of artificial organs, 2022, Volume: 45, Issue:11

    Topics: Anticoagulants; Fibrinogen; Gastrointestinal Hemorrhage; Heart Failure; Heart-Assist Devices; Hemolysis; Humans; Retrospective Studies; Thrombosis; Tissue Plasminogen Activator

2022
The association between fibrinogen-to-albumin ratio (FAR) and adverse prognosis in patients with acute decompensated heart failure at different glucose metabolic states.
    Cardiovascular diabetology, 2022, 11-12, Volume: 21, Issue:1

    Topics: Albumins; Blood Glucose; Fibrinogen; Glucose; Heart Failure; Humans; Prognosis

2022
Association between fibrinogen-to-albumin ratio and prognosis of patients with heart failure.
    European journal of clinical investigation, 2023, Volume: 53, Issue:10

    Topics: Aged; Aged, 80 and over; Albumins; Female; Fibrinogen; Heart Failure; Humans; Inflammation; Male; Middle Aged; Prognosis; Retrospective Studies

2023
Comparison of prognostic significance between serum fibrinogen and Global Registry of Acute Coronary Events score for prognosis of patients with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention.
    Coronary artery disease, 2020, Volume: 31, Issue:2

    Topics: Acute Coronary Syndrome; Age Factors; Aged; Angina, Unstable; Blood Pressure; Cohort Studies; Creatinine; Electrocardiography; Female; Fibrinogen; Heart Arrest; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardial Infarction; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; ROC Curve

2020
Left ventricular assist device driveline infections in three contemporary devices.
    Artificial organs, 2021, Volume: 45, Issue:5

    Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Heart Failure; Heart-Assist Devices; Humans; Leukocyte Count; Male; Middle Aged; Patient Readmission; Prosthesis-Related Infections; Retrospective Studies; Risk Assessment; Risk Factors

2021
Fibrinogen Level Predicts Outcomes in Critically Ill Patients with Acute Exacerbation of Chronic Heart Failure.
    Disease markers, 2021, Volume: 2021

    Topics: Aged; Aged, 80 and over; Biomarkers; Critical Illness; Female; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Treatment Outcome

2021
Soluble fibrinogen‑like protein 2 levels are decreased in patients with ischemic heart failure and associated with cardiac function.
    Molecular medicine reports, 2021, Volume: 24, Issue:2

    Topics: Aged; CD4 Antigens; Female; Fibrinogen; Heart Failure; Humans; Interleukin-2 Receptor alpha Subunit; Male; Middle Aged; Myocardial Ischemia; ROC Curve; T-Lymphocytes, Regulatory; Ventricular Function, Left

2021
Association Between the Inflammatory Biomarkers and Left Ventricular Systolic Dysfunction in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease.
    Balkan medical journal, 2017, 05-05, Volume: 34, Issue:3

    Topics: Aged; Biomarkers; C-Reactive Protein; Disease Progression; Echocardiography; Female; Fibrinogen; Heart Failure; Humans; Inflammation Mediators; Leukocyte Count; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Serbia; Ventricular Dysfunction, Left; Ventricular Function, Left

2017
Amniotic fluid embolism: principles of early clinical management.
    American journal of obstetrics and gynecology, 2020, Volume: 222, Issue:1

    Topics: Blood Coagulation Disorders; Blood Component Transfusion; Cardiopulmonary Resuscitation; Echocardiography; Embolism, Amniotic Fluid; Erythrocyte Transfusion; Extracorporeal Membrane Oxygenation; Factor VIII; Female; Fibrinogen; Heart Arrest; Heart Failure; Humans; Hypertension, Pulmonary; Plasma; Platelet Transfusion; Pregnancy; Vasoconstrictor Agents

2020
C-reactive protein, fibrinogen, and incident heart failure: combination procedure for statistical analysis.
    Journal of clinical hypertension (Greenwich, Conn.), 2013, Volume: 15, Issue:4

    Topics: C-Reactive Protein; Female; Fibrinogen; Heart Failure; Humans; Inflammation; Male

2013
C-reactive protein, fibrinogen, and incident heart failure in the Strong Heart Study population.
    Journal of clinical hypertension (Greenwich, Conn.), 2013, Volume: 15, Issue:4

    Topics: C-Reactive Protein; Female; Fibrinogen; Heart Failure; Humans; Inflammation; Male

2013
Association of a prothrombotic state with left-ventricular diastolic dysfunction in hypertension: a tissue-Doppler imaging study.
    Journal of hypertension, 2013, Volume: 31, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation; Cardiovascular Diseases; Cross-Sectional Studies; Diastole; Echocardiography, Doppler; Essential Hypertension; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Failure; Hemostasis; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Myocardium; Plasminogen Activator Inhibitor 1; Prothrombin; Risk Factors; Thrombosis; Tissue Plasminogen Activator; Young Adult

2013
The off-label utilization of prothrombin complex concentrate with cryoprecipitate as an alternative to plasma transfusion in bleeding patients with acute right ventricular failure.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2014, Volume: 61, Issue:3

    Topics: Acute Disease; Blood Coagulation Factors; Blood Transfusion; Factor VIII; Fibrinogen; Heart Failure; Hemorrhage; Humans; Off-Label Use; Ventricular Dysfunction, Right

2014
Steroid therapy attenuates acute phase reactant response among children on ventricular assist device support.
    The Annals of thoracic surgery, 2015, Volume: 99, Issue:4

    Topics: Acute-Phase Proteins; Adrenal Cortex Hormones; Biomarkers; C-Reactive Protein; Child; Child, Preschool; Cohort Studies; Extracorporeal Membrane Oxygenation; Female; Fibrinogen; Follow-Up Studies; Heart Failure; Heart-Assist Devices; Humans; Infant; Male; Retrospective Studies; Risk Assessment; Systemic Inflammatory Response Syndrome; Treatment Outcome

2015
Transplantation Effectiveness of Induced Pluripotent Stem Cells Is Improved by a Fibrinogen Biomatrix in an Experimental Model of Ischemic Heart Failure.
    Tissue engineering. Part A, 2015, Volume: 21, Issue:13-14

    Topics: Animals; Cell Proliferation; Cell Survival; Chickens; Disease Models, Animal; Extracellular Matrix; Fibrinogen; Heart Failure; Humans; Induced Pluripotent Stem Cells; Luminescent Measurements; Magnetic Resonance Imaging; Mice, SCID; Myocardial Ischemia; Time Factors; Tissue Distribution; Ventricular Function, Left

2015
Activated Hemostatic Biomarkers in Patients with Implanted Left Ventricle Assist Devices: Are Heparin and/or Clopidogrel Justified?
    Cardiology, 2015, Volume: 131, Issue:3

    Topics: Adult; Anticoagulants; Aspirin; Biomarkers; Clopidogrel; Drug Therapy, Combination; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Failure; Heart Ventricles; Heart-Assist Devices; Heparin; Humans; Male; Platelet Activation; Platelet Aggregation; Ticlopidine; Warfarin

2015
[MARKERS OF SYSTEMIC INFLAMMATORY RESPONSE IN PATIENTS OPERATED FOR COMPLICATIONS OF INFECTIOUS ENDOCARDITIS].
    Klinicheskaia meditsina, 2015, Volume: 93, Issue:7

    Topics: Adult; C-Reactive Protein; Cardiac Valve Annuloplasty; Endocarditis; Female; Ferritins; Fibrinogen; Heart Failure; Humans; Leukocyte Count; Male; Middle Aged; Patient Acuity; Postoperative Complications; Postoperative Period; Reproducibility of Results; Systemic Inflammatory Response Syndrome; Time Factors

2015
Effect of physical training on indices of platelet aggregation and fibrinogen concentration in patients with chronic heart failure.
    Medicina (Kaunas, Lithuania), 2015, Volume: 51, Issue:6

    Topics: Adenosine Diphosphate; Aged; Cardiac Rehabilitation; Chronic Disease; Dance Therapy; Epinephrine; Exercise Therapy; Female; Fibrinogen; Heart Failure; Humans; Male; Platelet Aggregation; Time Factors

2015
Relationship between inflammatory markers and clinical patterns of atrial fibrillation in patients with congestive heart failure.
    Kardiologia polska, 2008, Volume: 66, Issue:7

    Topics: Aged; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Comorbidity; Cross-Sectional Studies; Female; Fibrinogen; Heart Atria; Heart Failure; Humans; Hypertension; Male; Stroke Volume; Systole; Ultrasonography

2008
Anaemia as an inflammation-mediated condition during chronic heart failure. Possible role of fibrinogen.
    Acta cardiologica, 2008, Volume: 63, Issue:5

    Topics: Aged; Anemia; Case-Control Studies; Chronic Disease; Female; Fibrinogen; Heart Failure; Humans; Inflammation; Italy; Logistic Models; Male; Retrospective Studies; Risk Factors; Stroke Volume; Ventricular Function, Left

2008
Use of chromogenic assay of factor X to accept or reject INR results in Warfarin treated patients.
    Clinical medicine & research, 2009, Volume: 7, Issue:3

    Topics: Aged; Anticoagulants; Blood Coagulation; Chromogenic Compounds; Factor X; Female; Fibrin; Fibrinogen; Heart Failure; Humans; International Normalized Ratio; Lung Neoplasms; Prothrombin Time; Time Factors; Warfarin

2009
Lipoprotein-associated phospholipase A(2) and risk of congestive heart failure in older adults: the Cardiovascular Health Study.
    Circulation. Heart failure, 2009, Volume: 2, Issue:5

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Heart Failure; Humans; Incidence; Inflammation Mediators; Interleukin-6; Kaplan-Meier Estimate; Male; Population Surveillance; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; United States

2009
Fibrinogen and left ventricular myocardial systolic function: The Multi-Ethnic Study of Atherosclerosis (MESA).
    American heart journal, 2010, Volume: 160, Issue:3

    Topics: Aged; Aged, 80 and over; Atherosclerosis; Blood Viscosity; C-Reactive Protein; Female; Fibrinogen; Heart Failure; Humans; Image Processing, Computer-Assisted; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Ventricular Dysfunction, Left

2010
Platelet activation, oxidative stress and overexpression of inducible nitric oxide synthase in moderate heart failure.
    Clinical and experimental pharmacology & physiology, 2011, Volume: 38, Issue:10

    Topics: Adenosine Diphosphate; Arginine; Blood Platelets; C-Reactive Protein; Case-Control Studies; Collagen; Female; Fibrinogen; Heart Failure; Humans; Inflammation; Male; Middle Aged; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Platelet Activation; Platelet Aggregation; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances

2011
Markers of inflammation, metabolic risk factors, and incident heart failure in American Indians: the Strong Heart Study.
    Journal of clinical hypertension (Greenwich, Conn.), 2012, Volume: 14, Issue:1

    Topics: Aged; Biomarkers; C-Reactive Protein; Diabetes Mellitus; Female; Fibrinogen; Health Surveys; Heart Failure; Humans; Indians, North American; Inflammation; Male; Metabolic Syndrome; Middle Aged; Obesity; Prevalence; Proportional Hazards Models; Risk Factors; United States

2012
THE PAPWORTH PLUG - successful use of high dose fibrinogen concentrate and platelet concentrate in potential life-threatening complication after cardiopulmonary bypass surgery in a patient with Type 2M Vicenza von Willebrand Disease.
    Perfusion, 2012, Volume: 27, Issue:4

    Topics: Aged; Atrial Fibrillation; Blood Loss, Surgical; Cardiopulmonary Bypass; Fibrinogen; Heart Failure; Humans; Male; Platelet Transfusion; von Willebrand Disease, Type 2

2012
Thrombotic biomarkers and left ventricle characteristics as short-term predictors of thrombotic events in patients hospitalized for acute decompensated heart failure.
    European journal of internal medicine, 2012, Volume: 23, Issue:6

    Topics: Aged; Aged, 80 and over; Anticoagulants; Biomarkers; Echocardiography; Enoxaparin; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Pulmonary Embolism; Stroke Volume; Tissue Plasminogen Activator; Venous Thrombosis; Ventricular Function, Left

2012
Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.
    American journal of respiratory and critical care medicine, 2012, Nov-15, Volume: 186, Issue:10

    Topics: Aged; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Forced Expiratory Volume; Heart Failure; Humans; Inflammation Mediators; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Pneumonia; Pulmonary Disease, Chronic Obstructive; Risk; Vital Capacity

2012
Evaluation of hemostatic and fibrinolytic markers in dogs with ascites attributable to right-sided congestive heart failure.
    Journal of the American Veterinary Medical Association, 2012, Nov-15, Volume: 241, Issue:10

    Topics: Animals; Ascites; Biomarkers; Blood Coagulation Disorders; Cardiovascular Agents; Case-Control Studies; Dog Diseases; Dogs; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Failure; Male; Partial Thromboplastin Time; Prothrombin Time; Retrospective Studies

2012
Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure.
    The American journal of cardiology, 2002, Dec-01, Volume: 90, Issue:11

    Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Echocardiography; Endothelial Growth Factors; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Follow-Up Studies; Heart Failure; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Middle Aged; P-Selectin; Risk Factors; Severity of Illness Index; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Ventricular Function, Left

2002
Haemorheological and endothelial-dependent alterations in heart failure after ACE inhibitor, calcium antagonist and beta blocker.
    Clinical hemorheology and microcirculation, 2002, Volume: 27, Issue:3-4

    Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Arginine; Blood Viscosity; Calcium; Carbazoles; Carvedilol; Citrulline; Erythrocytes; Female; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide Synthase; Propanolamines; Ramipril; Time Factors; Treatment Outcome; Vascular Cell Adhesion Molecule-1; Vasodilator Agents

2002
Inhibition of platelet activation in congestive heart failure by aldosterone receptor antagonism and ACE inhibition.
    Thrombosis and haemostasis, 2003, Volume: 89, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Adhesion Molecules; Drug Therapy, Combination; Eplerenone; Fibrinogen; Heart Failure; Indoles; Male; Microfilament Proteins; Mineralocorticoid Receptor Antagonists; Nitric Oxide; P-Selectin; Phosphoproteins; Platelet Activation; Rats; Rats, Wistar; Renin-Angiotensin System; Spironolactone

2003
Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
    Clinical science (London, England : 1979), 2003, Volume: 105, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Biomarkers; Bisoprolol; Carbazoles; Carvedilol; Female; Fibrinogen; Heart Failure; Humans; Lipid Peroxides; Male; Middle Aged; Oxidative Stress; P-Selectin; Propanolamines; Statistics, Nonparametric; Treatment Failure; Vasodilator Agents; von Willebrand Factor

2003
CHANGES IN BLOOD VISCOSITY, HEMATOCRIT VALUE, AND FIBRINOGEN CONCENTRATION IN SUBJECTS WITH CONGESTIVE HEART FAILURE.
    Circulation, 1964, Volume: 30

    Topics: Blood Viscosity; Body Weight; Body Weights and Measures; Diet, Sodium-Restricted; Digitalis Glycosides; Diuretics; Drug Therapy; Fibrinogen; Geriatrics; Heart Failure; Hematocrit; Humans; Rest

1964
Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure.
    European journal of clinical investigation, 2003, Volume: 33, Issue:11

    Topics: Aged; Analysis of Variance; Biomarkers; Blood Viscosity; Disease-Free Survival; Female; Fibrinogen; Follow-Up Studies; Heart Failure; Humans; Interleukin-6; Male; Middle Aged; Prognosis; Thromboplastin; von Willebrand Factor

2003
Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    British journal of haematology, 2004, Volume: 126, Issue:1

    Topics: Adult; Aged; Anticoagulants; Antithrombin III; Biomarkers; Carrier Proteins; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Failure; Heart Transplantation; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Middle Aged; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Postoperative Period; Thrombomodulin; Tissue Plasminogen Activator; TNF Receptor-Associated Factor 2; Tumor Necrosis Factor Receptor-Associated Peptides and Proteins; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; von Willebrand Factor

2004
[Is slow coronary flow related with inflammation and procoagulant state?].
    Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2005, Volume: 5, Issue:1

    Topics: C-Reactive Protein; Case-Control Studies; Coronary Angiography; Female; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Plasminogen; Plasminogen Activator Inhibitor 1; Severity of Illness Index; Tissue Plasminogen Activator; von Willebrand Factor

2005
Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS).
    American heart journal, 2006, Volume: 151, Issue:2

    Topics: Aged; Algorithms; C-Reactive Protein; Cardiomegaly; Cohort Studies; Coronary Disease; Echocardiography; Female; Fibrinogen; Follow-Up Studies; Heart Atria; Heart Failure; Humans; Indians, North American; Male; Middle Aged; Myocardial Infarction; Risk Factors; Sex Factors; Stroke; United States

2006
Fibrinogen synthesis is increased in cachectic patients with chronic heart failure.
    International journal of cardiology, 2008, Oct-13, Volume: 129, Issue:3

    Topics: Aged; Cachexia; Chronic Disease; Fibrinogen; Heart Failure; Humans; Male

2008
Oxidized proteins in plasma of patients with heart failure: role in endothelial damage.
    European journal of heart failure, 2008, Volume: 10, Issue:3

    Topics: Aged; alpha 1-Antitrypsin; Cell Survival; Endothelial Cells; Endothelium, Vascular; Female; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Oxidative Stress; Proteomics

2008
Acute right heart failure during treatment with epsilon amino caproic acid (E-ACA).
    Acta medica Scandinavica, 1967, Volume: 182, Issue:3

    Topics: Acute Disease; Aminocaproates; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Breast Neoplasms; Female; Fibrinogen; Heart Failure; Humans; Middle Aged

1967
Factors affecting fibrinopeptide-A levels in patients with venous thromboembolism during anticoagulant therapy.
    Blood, 1982, Volume: 59, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Anticoagulants; Carcinoma, Squamous Cell; Female; Fibrinogen; Fibrinopeptide A; Heart Failure; Heparin; Humans; Leukemia, Lymphoid; Lupus Erythematosus, Systemic; Male; Middle Aged; Polycythemia Vera; Pulmonary Embolism; Sepsis; Thromboembolism

1982
[Characteristics of the disseminated intravascular coagulation syndrome in ischemic heart disease patients with congestive circulatory failure].
    Kardiologiia, 1981, Volume: 21, Issue:8

    Topics: Aged; Antithrombin III; Coronary Disease; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Syndrome; Thromboembolism

1981
[Changes of fibrinogen concentration and their prognostic value in acute myocardial infarct].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1981, Jul-06, Volume: 36, Issue:27

    Topics: Acute Disease; Adult; Aged; Female; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk; Thrombosis

1981
[Hemocoagulation and hemorheology in heart failure and the possible effects of glycosaminoglycans].
    Vnitrni lekarstvi, 1995, Volume: 41, Issue:1

    Topics: Aged; Antithrombin III; Blood Coagulation; Blood Viscosity; Female; Fibrinogen; Glycosaminoglycans; Heart Failure; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1

1995
[Plasma viscosity in the dog].
    Tierarztliche Praxis, 1996, Volume: 24, Issue:5

    Topics: Acute-Phase Proteins; Animals; Blood Viscosity; Cholesterol; Dog Diseases; Dogs; Female; Fibrinogen; Heart Failure; Microcirculation; Reference Values; Serum Globulins; Suppuration; Uremia; Uterine Diseases

1996
Arterial thrombosis in heart failure.
    Lancet (London, England), 1998, May-23, Volume: 351, Issue:9115

    Topics: Adenosine Diphosphate; Coronary Thrombosis; Epinephrine; Fibrinogen; Heart Failure; Hemorheology; Humans; Myocardial Infarction; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Pulmonary Edema; Vasoconstrictor Agents; von Willebrand Factor

1998
Plasma viscosity and fibrinogen in relation to haemodynamic findings in chronic congestive heart failure.
    European journal of heart failure, 1999, Volume: 1, Issue:3

    Topics: Adult; Aged; Biomarkers; Blood Viscosity; Chronic Disease; Disease Progression; Female; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Prognosis; Radionuclide Ventriculography; Stroke Volume

1999
Coagulation and fibrinolysis disorder in muscular dystrophy.
    Muscle & nerve, 2001, Volume: 24, Issue:3

    Topics: Adolescent; Adult; Blood Coagulation Disorders; Child; Creatine Kinase; Creatine Kinase, MM Form; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Heart Failure; Humans; Isoenzymes; Male; Muscular Dystrophy, Duchenne; Regression Analysis; Spinal Muscular Atrophies of Childhood

2001
Effects of acute exercise on hemorheological, endothelial, and platelet markers in patients with chronic heart failure in sinus rhythm.
    Clinical cardiology, 2001, Volume: 24, Issue:11

    Topics: Aged; Analysis of Variance; Biomarkers; Blood Viscosity; Case-Control Studies; Exercise; Female; Fibrinogen; Heart Failure; Hematocrit; Hemorheology; Humans; Male; Middle Aged; P-Selectin; Statistics, Nonparametric; Thromboembolism; von Willebrand Factor

2001
Blood coagulation system pathophysiology in acute myocardial infarction: the influence of anticoagulant treatment on laboratory findings.
    The Journal of laboratory and clinical medicine, 1979, Volume: 93, Issue:6

    Topics: Anticoagulants; Blood Coagulation Disorders; Fibrinogen; Heart Failure; Heparin; Humans; Myocardial Infarction; Warfarin

1979
[State of hemostasis and blood rheology in congestive circulatory insufficiency].
    Kardiologiia, 1979, Volume: 19, Issue:4

    Topics: Blood Viscosity; Coronary Disease; Erythrocyte Aggregation; Fibrinogen; Heart Failure; Hematocrit; Hemostasis; Humans; Myocardial Infarction; Platelet Aggregation; Thromboembolism

1979
[Fibrinogen metabolism in congestive circulatory insufficiency].
    Kardiologiia, 1977, Volume: 17, Issue:12

    Topics: Aged; Arrhythmias, Cardiac; Body Fluid Compartments; Coronary Disease; Fibrinogen; Half-Life; Heart Failure; Humans; Iodine Radioisotopes; Middle Aged; Mitral Valve Insufficiency; Rheumatic Heart Disease

1977
Synthesis rates of albumin and fibrinogen in patients with cardiac and pulmonary cachexia.
    Acta hepato-gastroenterologica, 1977, Volume: 24, Issue:2

    Topics: Aged; Albumins; Cachexia; Female; Fibrinogen; Heart Failure; Humans; Liver; Lung Diseases; Male; Middle Aged

1977
[Survival and state of patients during the 1st year after myocardial infarct (according to data of epidemiological study - myocardial infarct register)].
    Kardiologiia, 1975, Volume: 15, Issue:4

    Topics: Adult; Aged; Angina Pectoris; Blood Coagulation Disorders; Blood Glucose; Cholesterol; Fibrinogen; Follow-Up Studies; Heart Failure; Humans; Middle Aged; Myocardial Infarction; Prognosis; Recurrence; Thrombelastography; Thromboembolism; Time Factors

1975
In vitro pleural fluid clottability and fibrinogen content.
    Chest, 1975, Volume: 68, Issue:2

    Topics: Adult; Arthritis, Rheumatoid; Blood Coagulation Tests; Blood Proteins; Female; Fibrinogen; Fibrinolysis; Heart Failure; Hodgkin Disease; Humans; In Vitro Techniques; Liver Cirrhosis; Lung Neoplasms; Male; Middle Aged; Pleural Effusion; Pneumonia; Tuberculosis, Pulmonary

1975
Not the ESR again.
    Lancet (London, England), 1991, Apr-20, Volume: 337, Issue:8747

    Topics: Blood Sedimentation; Fibrinogen; Heart Failure; Humans

1991
Therapy of the Kasabach-Merritt syndrome with cryoprecipitate plus intra-arterial thrombin and aminocaproic acid.
    American journal of hematology, 1991, Volume: 36, Issue:4

    Topics: Aged; Aminocaproates; Antithrombin III; Blood Coagulation Disorders; Drug Therapy, Combination; Factor VIII; Fibrinogen; Heart Failure; Hemangioma; Humans; Liver Neoplasms; Male; Peptide Hydrolases; Platelet Count; Syndrome; Thrombin; Thrombocytopenia

1991
Inhibitor of the thrombin time in systemic amyloidosis: a common coagulation abnormality.
    Blood, 1991, Jun-15, Volume: 77, Issue:12

    Topics: Amyloidosis; beta-Alanine; Blood Coagulation Disorders; Fibrinogen; Heart Failure; Humans; Nephrotic Syndrome; Thrombin; Thrombin Time

1991
The erythrocyte sedimentation rate in congestive heart failure.
    The New England journal of medicine, 1991, Feb-07, Volume: 324, Issue:6

    Topics: Blood Sedimentation; Female; Fibrinogen; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged

1991
Passive smoking and the risk of heart attack or coronary death.
    The Medical journal of Australia, 1991, Jun-17, Volume: 154, Issue:12

    Topics: Adult; Aged; Australia; Case-Control Studies; Coronary Disease; Female; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Prevalence; Sex Factors; Tobacco Smoke Pollution

1991
Association of fibrinogen-fibrin-related antigen (F.R.-antigen) with postoperative deep-vein thrombosis and systemic complications.
    Lancet (London, England), 1972, Jan-22, Volume: 1, Issue:7743

    Topics: Aged; Angiography; Antigens; Female; Femoral Neck Fractures; Fibrin; Fibrinogen; Fibrinolysis; Heart Failure; Humans; Iodine Radioisotopes; Male; Neoplasm Metastasis; Postoperative Complications; Pulmonary Embolism; Radionuclide Imaging; Sepsis; Thrombophlebitis

1972
Studies on the blood fibrinolytic system in congestive cardiac failure.
    Clinical science, 1973, Volume: 45, Issue:1

    Topics: Adult; Aged; Alpha-Globulins; Arm; Constriction; Female; Fibrin; Fibrinogen; Fibrinolysis; Heart Defects, Congenital; Heart Diseases; Heart Failure; Humans; Macroglobulins; Male; Middle Aged; Plasminogen; Serum Globulins; Trypsin Inhibitors; Veins

1973
[Hereditary amyloidosis].
    La Nouvelle presse medicale, 1972, Oct-28, Volume: 1, Issue:38

    Topics: Amyloidosis; Chromosome Aberrations; Chromosome Disorders; Deafness; Familial Mediterranean Fever; Fibrinogen; Heart Failure; Humans; Joint Diseases; Neurologic Manifestations; Pain; Peripheral Nervous System Diseases; Peritonitis; Polyneuropathies; Portugal; Prognosis; Racial Groups; Skin Diseases; Thyroid Neoplasms

1972
The use of the fibrinogen turnover and the isotope scanning of the legs for the diagnosis of venous thrombosis in non surgical patients.
    Thrombosis et diathesis haemorrhagica, 1974, Dec-31, Volume: 32, Issue:2-3

    Topics: Acenocoumarol; Aged; Fibrin; Fibrinogen; Half-Life; Heart Failure; Heparin; Humans; Injections, Intravenous; Iodine Radioisotopes; Leg; Middle Aged; Radionuclide Imaging; Thrombophlebitis

1974
The influence of acenocumarole on the fibrinogen-turnover in normal subjects, venous thrombosis and congestive heart failure.
    Thrombosis et diathesis haemorrhagica, 1972, Dec-31, Volume: 28, Issue:3

    Topics: Acenocoumarol; Adult; Aged; Anticoagulants; Female; Fibrinogen; Half-Life; Heart Failure; Humans; Iodine Isotopes; Male; Middle Aged; Prothrombin Time; Thrombophlebitis

1972
Early determination of serum fibrin-fibrinogen degradation products in an intensive care unit.
    Acta clinica Belgica, 1972, Volume: 27, Issue:1

    Topics: Arrhythmias, Cardiac; Burns; Diabetic Coma; Fibrin; Fibrinogen; Heart Failure; Humans; Intensive Care Units; Lung Diseases, Obstructive; Myocardial Infarction; Poisoning; Shock, Cardiogenic; Tetanus

1972
Jaundice following cardiopulmonary by-pass.
    Annales chirurgiae et gynaecologiae Fenniae, 1973, Volume: 62, Issue:1

    Topics: Age Factors; Alanine Transaminase; Aortic Valve; Aspartate Aminotransferases; Blood Donors; Chemical and Drug Induced Liver Injury; Extracorporeal Circulation; Fibrinogen; Heart Failure; Heart-Lung Machine; Hemolysis; Hepatitis; Hepatitis A; Humans; Hypoxia; Jaundice; Liver Diseases; Mitral Valve; Postoperative Complications; Sulfobromophthalein; Time Factors; Transfusion Reaction

1973
Venous thromboses in myocardial infarction. Comparison in heparin dosage.
    British heart journal, 1973, Volume: 35, Issue:5

    Topics: Acute Disease; Female; Fibrinogen; Heart Failure; Heparin; Humans; Injections, Intravenous; Iodine Radioisotopes; Leg; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Thrombophlebitis

1973
Leg vein thrombosis diagnosed by 125I-fibrinogen test after acute myocardial infarction.
    Annals of clinical research, 1973, Volume: 5, Issue:6

    Topics: Acute Disease; Adult; Age Factors; Aged; Anticoagulants; Female; Fibrinogen; Heart Failure; Humans; Iodine Radioisotopes; Leg; Male; Methods; Middle Aged; Myocardial Infarction; Sex Factors; Tachycardia; Thrombophlebitis; Time Factors; Ventricular Fibrillation

1973
Some properties of the anticoagulant factor of aged pooled plasma.
    Thrombosis et diathesis haemorrhagica, 1969, Aug-31, Volume: 22, Issue:1

    Topics: Ampicillin; Anemia, Hypochromic; Animals; Anticoagulants; Blood Cell Count; Blood Coagulation Tests; Blood Preservation; Blood Transfusion; Digitoxin; Epistaxis; Fibrinogen; Heart Failure; Hematocrit; Hemoglobinometry; Humans; Immunoelectrophoresis; Immunoglobulin G; Infant; Male; Plasma; Shock, Hemorrhagic; Thrombocytopenia

1969
Serum cholinesterase and euglobulin lysis time in chronic cor pulmonale.
    British heart journal, 1969, Volume: 31, Issue:4

    Topics: Adult; Aged; Arteriosclerosis; Cholesterol; Cholinesterases; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Heart Failure; Humans; Hypoxia; Liver; Male; Middle Aged; Pulmonary Heart Disease; Serum Globulins; Time Factors

1969